Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 12/20 | 0.40 |
| ▸ | GLP1R | P43220 | 7/20 | 0.39 |
| ▸ | GCGR | P47871 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tryptophan SCHEMBL5820703 | 0.95 | PTH1R (0.39) | PTH1RGLP1R | |
| Phenylalanine SCHEMBL6479234 | 0.95 | GLP1R (0.35) | PTH1RGLP1RGCGR | |
| Arginine SCHEMBL6438609 | 0.94 | PTH1R (0.41) | PTH1RGLP1R | |
| Tryptophan SCHEMBL10623343 | 0.92 | GLP1R (0.39) | PTH1RGLP1RGCGR | |
| Arginine SCHEMBL8152157 | 0.92 | GLP1R (0.38) | PTH1RGLP1R | |
| Phenylalanine SCHEMBL6437396 | 0.91 | GLP1R (0.34) | PTH1RGLP1RGCGR | |
| Tryptophan SCHEMBL9295342 | 0.91 | PTH1R (0.40) | PTH1RGLP1RGCGR | |
| Phenylalanine SCHEMBL6438432 | 0.91 | GLP1R (0.34) | PTH1RGLP1RGCGR | |
| Tryptophan SCHEMBL10619278 | 0.91 | GLP1R (0.41) | PTH1RGLP1RGCGR | |
| Phenylalanine SCHEMBL6563941 | 0.90 | GLP1R (0.34) | PTH1RGLP1RGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1562578-A1 | THERAPEUTIC DELIVERY OF CARBON MONOXIDE TO EXTRACORPOREAL AND ISOLATED ORGANS | Hemocorm Limited (GB) | 2005-08-17 | — | — | EP | disclosed |
| WO-2004045598-A1 | THERAPEUTIC DELIVERY OF CARBON MONOXIDE TO EXTRACORPOREAL AND ISOLATED ORGANS | HEMOCORM LIMITED (GB) | 2004-06-03 | — | — | WO | disclosed |